UT-MD Anderson Cancer Center: Some Breast Cancer Patients With High Responses To Chemotherapy May Not Need Surgery
October 26, 2022
October 26, 2022
HOUSTON, Texas, Oct. 26 (TNSjou) -- The University of Texas's MD Anderson Cancer Center issued the following news release on Oct. 25, 2022:
* * *
MD Anderson-developed biopsy protocol identifies patients at low risk of recurrence
* * *
Patients with early-stage breast cancer who had a pathologic complete response (pCR) to neoadjuvant chemotherapy may be able to skip surgery and receive standard radiation treatment with a low chance of dise . . .
* * *
MD Anderson-developed biopsy protocol identifies patients at low risk of recurrence
* * *
Patients with early-stage breast cancer who had a pathologic complete response (pCR) to neoadjuvant chemotherapy may be able to skip surgery and receive standard radiation treatment with a low chance of dise . . .